Mulder marcel (46 resultados)

Soft cover. Condición: Good. Copyright 1996, reprinted in 1997 with corrections, reprinted 2000, 2003. Pages are clean, unmarked, illustrated throughout with figures and tables. The glossy green cover of this 564-page paperback is scuffed and bumped at corners. Edges are darkened at corners, flyleaf is folded and pages up to 117 are dented at bottom corner. Price includes shipping via USPS media mail to addresses in the USA. International buyers, please contact us via Abebooks for shipping surcharge to be added to buyer's invoice.…

Condición: As New. Unread book in perfect condition.

Condición: New.

Condición: New. In English.

Condición: New.

Condición: Sehr gut. 2nd edition. 7 Blatt, 654 Seiten Softcover, Broschur in sehr gutem Zustand, innen wie außen. Minimalste Lagerspuren. Bitte beachten Sie unsere Bilder. DK-50-04A Sprache: Englisch Gewicht in Gramm: 822 Taschenbuch, Maße: 16.03 cm x 3.35 cm x 23.98 cm.

Condición: As New. Unread book in perfect condition.

Condición: Very Good.

Condición: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,1000grams, ISBN:9780792342489.

Condición: Very Good.

Condición: New. In English.

Condición: new.

HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Condición: New.

Condición: New. 2022. Hardback. . . . . .

Hardback. Condición: New. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.…

Hardcover. Condición: Brand New. 1st edition. 307 pages. 9.50x6.25x1.00 inches. In Stock.

Hardcover. Condición: new. Hardcover. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels in the context of current issues and future trends, including those related to COVID-19 and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Condición: New. 2022. Hardback. . . . . . Books ship from the US and Ireland.

Hardback. Condición: New. New copy - Usually dispatched within 4 working days.

Hardback. Condición: New. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.…

Hardcover. Condición: new. Hardcover. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels in the context of current issues and future trends, including those related to COVID-19 and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

Condición: As New. Unread book in perfect condition.

Condición: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.…

Condición: New. In English.

Condición: New. In English.

Condición: New.

Condición: New.

Condición: As New. Unread book in perfect condition.

Paperback. Condición: New. Second Edition 1996. III . 2 Preparation of synthetic membranes 72 III . 3 Phase inversion membranes 75 III. 3. 1 Preparation by evaporation 76 III . 3. 2 Precipitation. from the vapour phase 76 III . 3. 3 Precipitation by controlled evaporation 76 Thermal precipitation 76 III . 3. 4 III . 3. 5 Immersion precipitation 77 Preparation techniques for immersion precipitation 77 III . 4 Flat membranes 77 III . 4. 1 78 III . 4. 2 Tubular membranes 81 III . 5 Preparation techniques for composite membranes 82 III. 5. 1 Interfacial polymerisation Dip-coating 83 III . 5. 2 III . 5. 3 Plasma polymerisation 86 III . 5. 4 Modification of homogeneous dense membranes 87 III . 6 Phase separation in polymer systems 89 III . 6. 1 Introduction 89 III . 6. 1. 1 Thermodynamics 89 III . 6. 2 Demixing processes 99 III . 6. 2. 1 Binary mixtures 99 III . 6. 2. 2 Ternary systems 102 III . 6. 3 Crystallisation 104 III . 6. 4 Gelation 106 III . 6. 5 Vitrification 108 III . 6. 6 Thermal precipitation 109 III . 6. 7 Immersion precipitation 110 III . 6. 8 Diffusional aspects 114 III . 6. 9 Mechanism of membrane formation 117 III. 7 Influence of various parameters on membrane morphology 123 III. 7. 1 Choice of solvent-nonsolvent system 123 III . 7. 2 Choice of the polymer 129 III . 7. 3 Polymer concentration 130 III . 7. 4 Composition of the coagulation bath 132 III . 7. 5 Composition of the casting solution 133 III . 7.…